# Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung Disease

> **NCT07129707** · NA · COMPLETED · sponsor: **Dieulefit Santé Centre de Réadaptation** · enrollment: 15 (actual)

## Conditions studied

- Interstitial Lung Disease (ILD)

## Interventions

- **OTHER:** Exercise testing

## Key facts

- **NCT ID:** NCT07129707
- **Lead sponsor:** Dieulefit Santé Centre de Réadaptation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07129707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07129707, "Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07129707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*